GHRL and oculopharyngeal muscular dystrophy: As a new potential biomarker, ghrelin can predict the malignant trend of OPMD, including OLP, and can be used as a monitoring index for non-invasive screening of malignant changes of OPMD in the healthy population by molecular epidemiology.